Prescribing Trends of Antidiabetic Fixed dose combinations in a rural tertiary care teaching hospital in Central India: An Observational, cross-sectional study Santra Diptendu*, Totade Sangita J.N. Medical College, Sawangi (M), Wardha (Maharashtra) *Corresponding Author E-mail: diptendusantra@gmail.com
Online published on 2 May, 2015. Abstract Objective To assess prescribing trends of Fixed dose combination antidiabetics in Diabetes Mellitus patients. Materials and Methods An observational, cross-sectional study was carried out in the Medicine OPD of AVBRH, Sawangi(M), Wardha. A total of 500 Diabetes Mellitus Patients were selected for the study after fulfilling the inclusion/exclusion criteria. Results Out of 500 patients 484 patients were of type-II DM in whom 5 FDCs were prescribed. Maximum prescribed FDCs were of Metformin and sulfonylurea Metformin + Glimepiride (n=74) and Metformin + Glipizide (n=37). Following FDCs were Metformin + Voglibose (n=52), Glimepiride + Pioglitazone (n=18) and least prescribed was Metformin+ Glimepiride + Voglibose (n=10). All the drugs were prescribed by brand names. Total of 191 patients (39.46%) were prescribed Antidiabetic FDCs. Conclusion All Antidiabetic FDCs prescribed were rational. FDCs in Antidiabetics are useful in combination therapy for increasing patient compliance and achieving euglycemia more effectively. Top Keywords Prescribing trends, Diabetes Mellitus, Fixed dose combinations. Top |